Operational Update and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Animal Models - 400% Outperformance of Gold Standard
- Break Through Animal Model Results
- March 2019 Quarterly Operational Update and App4C
- Collaboration Agreement - siRNA delivery
- Flagship Program - Successful Animal Models
Later from PYC Therapeutics
- Company Presentation - July 2019
- Phylogicas Technology is Effective in Human Cells
- Response to ASX Aware Query
- Successful Time - Course Studies in Animals
- Successful Competitive Drug Evaluation in Animals
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics